Q2 STOCKS TO BUY

Call Players Take Aim at Tanking Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics, Inc. (FOLD) is short-sale restricted, after the company announced a delay on its migalastat new drug application

Oct 2, 2015 at 11:33 AM
facebook X logo linkedin


Amicus Therapeutics, Inc. (NASDAQ:FOLD) is among the biggest losers on the Nasdaq, after the company said its new drug application (NDA) for its experimental migalastat treatment likely won't be submitted to the Food and Drug Administration (FDA) by year-end. At last check, the shares have tanked 40% at $8.23, and have landed on the short-sale restricted list. Meanwhile, activity has spiked in the stock's options pits.

Most notably, FOLD call volume is running at 21 times the normal intraday rate, and about 3.5 times the pace of puts. The most active option is the now out-of-the-money January 2016 10-strike call, where 2,000 contracts are on the tape -- half of which transpired as a block.

This represents a departure from the longer-term put-skewed trend. Specifically, FOLD's 10-day International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) put/call volume ratio of 0.90 ranks in the 82nd percentile of its annual range. In other words, traders have been buying to open bearish bets over bullish at a faster-than-usual clip of late.

On the flip side, the brokerage bunch has taken a shine to Amicus Therapeutics, Inc. (NASDAQ:FOLD). Three-quarters of analysts have doled out "strong buy" endorsements on the stock, while its consensus 12-month price target of $23.10 nearly triples the current perch (and would mark record-high levels). If today's disappointing news -- and resultant bear gap -- prompt a round of downgrades and/or price-target cuts, FOLD could face even more pressure.
 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter